NCT02912507

Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal

An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: Cutera Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser

Detailed description

This is an open-label, split-tattoo, single-center prospective, comparison study in up to 20 male or female subjects, age 18 to 65 years, who desire laser removal of a tattoo containing single or multi-color ink. Subjects will receive laser treatments, and will be followed at 6 weeks.

Conditions

• Tattoo Removal

Interventions

Type	Name	Description
DEVICE	Cutera enlighten laser	high-powered, Q-switched 670nm Picosecond laser system indicated for tattoo removal
DEVICE	CynoSure PicoSure 755nm laser	high-powered, Q-switched Alexandrite system that delivers laser energy in the 755 nm wavelength and has received FDA clearance (K133364) for tattoo and benign pigmented lesion removal.

Timeline

• Start date: 2016-09-09
• Primary completion: 2017-08-16
• Completion: 2017-08-16
• First posted: 2016-09-23
• Last updated: 2023-10-04
• Results posted: 2023-10-04

Locations

1 site across 1 country: United States